Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
2139341 | Leukemia Research | 2006 | 7 Pages |
Abstract
Agnogenic myeloid metaplasia (AMM) is characterized by bone marrow fibrosis and enhanced proliferation of megakaryocytes and CD34+ cells. We have analyzed the factors that could lead to reduced expression of TGF β1RII in CD34+ cells of AMM patients. Our results demonstrate absence of mutations in the coding region and the promoter of this gene and absence of CpG methylation of its promoter in AMM patients. Further studies on transcriptional regulation of TGF β1RII involving its cis-regulatory elements, the interacting transcription factors and their association with HDAC will provide valuable information on the pathogenesis of AMM and are under current investigation.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Kirugaval C. Hemavathy, Tsong H. Chang, Haowei Zhang, William Charles, Amit Goldberg, Sramila Aithal, Allan D. Novetsky, Jen C. Wang,